تحميل
NASDAQTechnologySoftware - Application
أحدث البيانات المتاحة
8.30 US$
−0.10 US$ · -1.19%
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
الإغلاق السابق
8.30 US$
−0.10 US$ · -1.19%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
نطاق اليوم
السعر الحالي 8.30 US$
نطاق 52 أسبوعًا
السعر الحالي 8.30 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
65
أقل من القيمة
المشاعر
48
مختلط
المخاطر
43
مخاطر أعلى من المعتاد
الزخم
52
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
نطاق اليوم
السعر الحالي 8.30 US$
نطاق 52 أسبوعًا
السعر الحالي 8.30 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (EUR) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 257.07 مليون EUR | 266.77 مليون EUR | 256.13 مليون EUR | 232.02 مليون EUR | 205.45 مليون EUR |
| تكلفة البضاعة المباعة | 110.16 مليون EUR | 115.94 مليون EUR | 111 مليون EUR | 103.26 مليون EUR | 87.28 مليون EUR |
| الربح الإجمالي | 146.91 مليون EUR | 150.83 مليون EUR | 145.13 مليون EUR | 128.77 مليون EUR | 118.17 مليون EUR |
| البحث والتطوير | 44.27 مليون EUR | 44.4 مليون EUR | 38.1 مليون EUR | 37.57 مليون EUR | 26.89 مليون EUR |
| مصاريف البيع والمصاريف العمومية والإدارية | 96.32 مليون EUR | 101.22 مليون EUR | 94.89 مليون EUR | 93.02 مليون EUR | 77.59 مليون EUR |
| نفقات التشغيل | 141.97 مليون EUR | 141.39 مليون EUR | 139.51 مليون EUR | 131.64 مليون EUR | 105.96 مليون EUR |
| دخل الفوائد | 3.81 مليون EUR | 4.25 مليون EUR | 4.45 مليون EUR | 1.4 مليون EUR | 777.74 ألف EUR |
| مصاريف الفوائد | 5.39 مليون EUR | 1.65 مليون EUR | 2.09 مليون EUR | 2.92 مليون EUR | 3.36 مليون EUR |
| الاستهلاك والإطفاء | 20.85 مليون EUR | 21.76 مليون EUR | 21.57 مليون EUR | 22.57 مليون EUR | 20.55 مليون EUR |
| الدخل التشغيلي | 4.94 مليون EUR | 9.43 مليون EUR | 5.62 مليون EUR | −2.87 مليون EUR | 12.22 مليون EUR |
| صافي الدخل | 7.41 مليون EUR | 13.44 مليون EUR | 6.72 مليون EUR | −2.12 مليون EUR | 13.15 مليون EUR |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
10.00 US$
ارتفاع محتمل بنسبة 20.48%صناديق متداولة تفصح عن تعرضها لهذا السهم.
The 3D Printing ETFPRNT2.87 مليون4.64%58.7 مليون USD0.66%25.50 US$+0.80%
Pacer BlueStar Engineering the Future ETFBULD328.78 ألف2.21%14.88 مليون USD0.49%37.238 US$+0.94%
ActivePassive International Equity ETFAPIE254.74 ألف0.02%1.14 مليار USD0.45%38.56 US$+0.65%
State Street SPDR S&P International Small Cap ETFGWX216.35 ألف0.02%907.87 مليون USD0.40%45.56 US$+0.93%
State Street SPDR Portfolio Developed World ex-US ETFSPDW83.35 ألف0.00%40.46 مليار USD0.03%49.98 US$+0.64%The 3D Printing ETFPRNTPacer BlueStar Engineering the Future ETFBULDActivePassive International Equity ETFAPIEState Street SPDR S&P International Small Cap ETFGWXState Street SPDR Portfolio Developed World ex-US ETFSPDWالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
